American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Ocean Biomedical, Inc. (OCEA)

$0.00 +300.00% OTC: OCEA · 15-min delayed

NEW YORK, New York
Public · OTC: OCEA

-$9.5MNet income

OCEAOTC

About Ocean Biomedical, Inc.

OCEAN BIOMEDICAL INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: OCEA
Headquarters: NEW YORK, New York
Industry: Pharmaceuticals

Registry IDs

Ticker: OCEA OTC
SEC CIK: 1869974
EIN: 871309280
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show Ocean Biomedical, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/ocean-biomedical-inc/"><img src="https://americancompanies.com/badge/ocean-biomedical-inc.svg" alt="Ocean Biomedical, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Ocean Biomedical, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Net income: -$9.5M
Total assets: $902.0K
Operating margin: 185.6%
Net margin: 463.3%

Source: SEC EDGAR · updated Jun 8, 2026

Multi-year

Revenue & profit trend

FY2023

FY2024

Revenue Net income

FY 2024

Financial statements

Income statement

Revenue: -$2.0M
Operating expenses: $3.8M
Operating income: -$3.8M
Net income: -$9.5M
EPS (basic): $-0.34
EPS (diluted): $-0.34

Balance sheet

Total assets: $902.0K
Current assets: $812.0K
Total liabilities: $98.5M
Current liabilities: $33.9M
Shareholders’ equity: -$97.6M

Cash flow

Operating cash flow: -$4.2M
Investing cash flow: $780.0K
Financing cash flow: $3.4M
Net cash flow: $0

Statements via Polygon.io (SEC filings)

OTC: OCEA

$0.00 +300.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.00 $0.01

52-week range

EPS (diluted): $-0.34
Open: —
Day range: –
Prev close: —
Volume: —

Ocean Biomedical, Inc. (OCEA) Stock Price

Reported a net loss of $9.5M.
Revenue declined 16% from FY2023 to FY2024.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Ocean Biomedical, Inc..

Write a review

Newsroom

News about Ocean Biomedical, Inc.

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q GlobeNewswire Inc. · 2024-11-22 · negative Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter GlobeNewswire Inc. · 2024-10-22 · negative Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses GlobeNewswire Inc. · 2024-10-01 · positive Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024 GlobeNewswire Inc. · 2024-06-05 Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q GlobeNewswire Inc. · 2024-05-30 Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease GlobeNewswire Inc. · 2024-05-16

News & sentiment via Polygon.io

FAQ

Ocean Biomedical, Inc.: frequently asked questions

Is Ocean Biomedical, Inc. an American company?

Ocean Biomedical, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Ocean Biomedical, Inc. headquartered?

Ocean Biomedical, Inc. is headquartered in New York, New York, United States.

Is Ocean Biomedical, Inc. publicly traded?

Yes — Ocean Biomedical, Inc. is a publicly traded company. Its stock trades under the ticker symbol OCEA on the OTC.

What does Ocean Biomedical, Inc. do?

Ocean Biomedical, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore